This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tianjin Institute of Pharmaceutical Research Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovator Xuemin Zheng: Pioneering Antiplatelet Compounds
Introduction
Xuemin Zheng is an esteemed inventor located in Tianjin, China, recognized for his significant contributions to the pharmaceutical industry. With a prolific career, Zheng has made strides in developing innovative compounds aimed at addressing critical medical challenges.
Latest Patents
Zheng holds a patent for "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof." This patent presents a compound characterized by a specific structural formula, aimed at providing a solution to clopidogrel resistance, as well as minimizing the severe hemorrhagic side effects and improving the stability of existing drugs. The invention includes a crystalline form of the compound, alongside its preparation method and potential use in pharmaceutical compositions. Compounds derived from this patent are envisioned to be developed into ADP receptor antagonist antiplatelet agents, demonstrating clear therapeutic effects and enhanced safety profiles.
Career Highlights
Zheng is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where his research and innovation have fostered advancements in drug development. His commitment to enhancing pharmaceutical efficacy through innovative chemistry has underscored his career.
Collaborations
Throughout his career, Xuemin Zheng has collaborated with distinguished colleagues, including Changjiang Huang and Shijun Zhang. These collaborations have played a vital role in the development of new compounds and the sharing of ideas within the industry, further propelling advancements in pharmaceutical research.
Conclusion
Xuemin Zheng's contributions to the field of pharmaceuticals, particularly through his innovative patent, demonstrate his commitment to improving patient outcomes. His work at the Tianjin Institute of Pharmaceutical Research Co., Ltd. continues to inspire future developments in antiplatelet therapies, showcasing the transformative power of inventive research in addressing pressing medical needs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile